Back |
home / stock / cvm / cvm message board
Subject | By | Source | When |
---|---|---|---|
Patience and time in a penny stock is | fung_derf | investorshub | 04/14/2023 2:13:53 PM |
Fine with me - gives me more time | drkazmd65 | investorshub | 04/13/2023 3:40:42 PM |
Hey Kids! Its Math time! | sushifishman | investorshub | 04/12/2023 2:17:59 PM |
Chirp Chirp | sushifishman | investorshub | 04/11/2023 11:36:55 PM |
Blame Game | sushifishman | investorshub | 04/10/2023 4:32:52 PM |
Comments to Shareholders. | rdneum | investorshub | 04/10/2023 3:45:41 PM |
Im laughing! | sushifishman | investorshub | 04/10/2023 2:36:35 PM |
When is the peer review article in a | sushifishman | investorshub | 04/08/2023 1:27:37 PM |
Happy Passover Big offering coming in June About $25m | sushifishman | investorshub | 04/06/2023 1:58:11 PM |
How deep to the bottom will this garbage | Master of Puppets | investorshub | 04/04/2023 8:37:12 AM |
April Fools Stinker headed to $1 | sushifishman | investorshub | 04/03/2023 2:37:00 PM |
Nugget Time I have seen the light! | sushifishman | investorshub | 04/01/2023 4:44:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Cel-Sci Corporation Company Name:
CVM Stock Symbol:
NYSE Market:
CEL-SCI Corp (NASDAQ:CVM) shares are trading higher by 18.6% to $1.98 during Wednesday’s session after the company received positive feedback...
Critical milestone achieved—the FDA accepted CEL-SCI’s selection criteria defining the Multikine target population before surgery Selected patient population had 73% survival with Multikine vs. 45% without Multikine based on analysis of completed 928-patient Phase 3 rand...
CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Mario Gobbo to its Board of Directors. Mr. Gobbo has nearly 40 years of banking and corporate finance experience in healthcare and energy. His expertise encompasses venture capital and private equity as well as in...